請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78073
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林峰輝 | |
dc.contributor.author | Ping-Cheng Lin | en |
dc.contributor.author | 林秉辰 | zh_TW |
dc.date.accessioned | 2021-07-11T14:41:23Z | - |
dc.date.available | 2021-11-02 | |
dc.date.copyright | 2016-11-02 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-21 | |
dc.identifier.citation | 1. Grant, T. M., Thompson, M. S., Urban, J., & Yu, J. (2013). Elastic fibres are broadly distributed in tendon and highly localized around tenocytes. J Anat, 222(6), 573-579.
2. Raven PB, Wasserman DH, Squires WG Jr, Muray TD (2013). Exercise physiology: an integrated approach. Wadsworth Cengage Learning, Belmont, CA 3. Fredberg, U., & Stengaard-Pedersen, K. (2008). Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports, 18(1), 3-15 4. Abate, M., Silbernagel, K. G., Siljeholm, C., Di Iorio, A., De Amicis, D., Salini, V., Paganelli, R. (2009). Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res Ther, 11(3), 235 5. Dixon J1, Howe TE.(2005).Quadriceps force generation in patients with osteoarthritis of the knee and asymptomatic participants during patellar tendon reflex reactions: an exploratory cross-sectional study.BMC Musculoskelet Disord;6:46. 6. Couppé C (2012)The effects of immobilization on the mechanical properties of the patellar tendon in younger and older men. Clin Biomech (Bristol, Avon). Nov;27(9):949-54. 7. H.R.C. Screen, D.E. Birk, K.E. Kadler, F Ramirez, and M.F. Young(2015).Tendon Functional Extracellular Matrix.J Orthop Res.; 33(6): 793–799. 8. Von wehren L(2015).The effect of subacromial injections of autologous conditioned plasma versus cortisone for the treatment of symptomatic partial rotator cuff tears.Knee Surg Sports Traumatol Arthrosc. May 28 9.Paavola M, Kannus P, Paakkala T, Pasanen M, Järvinen M.( 2000) Long-term prognosis of patients with Achilles tendinopathy. An observational 8-year follow-up study. Am J Sports Med.;28:634–642. 10. Fenwick SA, Hazleman BL, Riley GP. (2002)The vasculature and its role in the damaged and healing tendon. Arthrit Res; 4(4)252–260. 11. Carr AJ, Norris SH. (1989) The blood supply of the calcaneal tendon. J Bone Joint Surg Br; 71-B: 100–101 12. Astrom, M., & Westlin, N. (1994). Blood flow in the human Achilles tendon assessed by laser Doppler flowmetry. J Orthop Res, 12(2), 246-252 13. Sai-Chuen Fu,Christer Rolf, Yau-Chuk Cheuk,Pauline PY Lui, and Kai-Ming.(2010). Chancorresponding author1,2Deciphering the pathogenesis of tendinopathy: a three-stages process.Sports Med Arthrosc Rehabil Ther Technol.2: 30. 14. Sandra Gouveia-Figueira, Malin L. Nording,(2015).Serum Levels of Oxylipins in Achilles Tendinopathy: An Exploratory Study. PLoS One. ; 10(4) 15. D. U. Jeong, C.-R. Lee, J. H. Lee, J. Pak, L.-W. Kang, B. C. Jeong, and S. H. Lee,(2014).Clinical Applications of Platelet-Rich Plasma in Patellar Tendinopathy.Biomed Res Int. 16. Ivo JH Tiemessen, P Paul FM Kuijer,(2009).Risk factors for developing jumper's knee in sport and occupation: a review.BMC Res Notes.2: 127. 17. O'Brien, M. (1992). Functional anatomy and physiology of tendons. Clin Sports Med, 11(3), 505-520 18. Bradley, J. P., & Tibone, J. E. (1990). Percutaneous and open surgical repairs of Achilles tendon ruptures. A comparative study. Am J Sports Med, 18(2), 188-195. 19. Coombs, R. R. H., Klenerman, L., Narcisi, P., Nichols, A., & Pope, F. M. (1980). Collagen typing in Achilles tendon rupture. In Proceedings of the British Orthopaedic Research. Society. J. Bone and Joint Surg, 62(258). 20. Reale, E., Benazzo, F., & Ruggeri, A. (1981). Differences in the microfibrillar arrangement of collagen fibrils. Distribution and possible significance. J Submicrosc Cytol, 13(2), 135-143. 21. Robins, S. P. (1988). Functional properties of collagen and elastin. Baillieres Clin Rheumatol, 2(1), 1-36. 22. Jean-François Kaux, Bénédicte Forthomme.(2011).Current Opinions on Tendinopathy.J Sports Sci Med. 10(2): 238–253. 23. Wei Zhu, Jing Xu.(2014)Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression.J Radiat Res.55(6): 1056–1065. 24. Jin Zhou, Benjamin Livingston Farah.(2014).Epigallocatechin-3-Gallate (EGCG), a Green Tea Polyphenol, Stimulates Hepatic Autophagy and Lipid Clearance. PLoS One.9(1) 25. Brahma N. Singh,Sharmila Shankar, Rakesh K. Srivastava.(2011).Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.Biochem Pharmacol. 82(12): 1807–1821. 26. Yoshiko Nakae, Olivier M. Dorchies Peter J. Stoward. (2012).Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea.Histochem Cell Biol.137(6): 811–827. 27. C Kurz, I Ungerer, U Lipka.(2010).The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by ß-amyloid peptide.Br J Pharmacol.160(2): 246–257. 28. Denitsa Docheva, Sebastian A.(2014). Müller.Biologics for tendon repair.Adv Drug Deliv Rev. 84: 222–239. 29. James H-C. Wang, Qianping Guo.(2011).Tendon biomechanics and mechanobiology - a mini-review of basic concepts and recent advancements.J Hand Ther.25(2): 133–141. 30. Hui B. Sun, Daniel J. Leong.(2015).Biology and mechano-response of tendon cells: progress overview and perspectives.J Orthop Res.33(6): 785–792. 31. Wayne Yuk Wai Lee, Ph.D.,Pauline Po Yee Lui, Ph.D.(2011).Hypoxia-Mediated Efficient Expansion of Human Tendon–Derived Stem Cells In Vitro.Tissue Eng Part A.18(5-6): 484–498. 32. Michael J. Mienaltowski, D.V.M., Ph.D., Sheila M. Adams.(2013). M.S.Regional Differences in Stem Cell/Progenitor Cell Populations from the Mouse Achilles Tendon.Tissue Eng .19(1-2): 199–210. 33. Marie-Justine Guerquin, Benjamin Charvet.(2013).Transcription factor EGR1 directs tendon differentiation and promotes tendon repair. J Clin Invest.123(8): 3564–3576. 34. Mohanad Kh Al-ani, Kang Xu.(2015). Study of Bone Marrow Mesenchymal and Tendon-Derived Stem Cells Transplantation on the Regenerating Effect of Achilles Tendon Ruptures in Rats. Stem Cells Int. 35. Gundula Schulze-Tanzil, Onays Al-Sadi.(2012).Decellularized Tendon Extracellular Matrix—A Valuable Approach for Tendon Reconstruction? Cells.1(4): 1010–1028. 36. Tatiana Y. Kostrominova, Susan V.(2013).Age-related changes in structure and extracellular matrix protein expression levels in rat tendons.Age (Dordr). 35(6): 2203–2214. 37. Steven P Arnoczky, Michael Lavagnino.(2007).The mechanobiological aetiopathogenesis of tendinopathy: is it the over-stimulation or the under-stimulation of tendon cells? Int J Exp Pathol.88(4): 217–226. 38. Jennifer H Shepherd , Hazel R C Screen.(2013).Fatigue loading of tendon.Int J Exp Pathol.94(4): 260–270. 39. Wren, T.A.L. (2003), Effects of creep and cyclic loading on the mechanical properties and failure of human achilles tendons, Ann. Biomed. Eng., 31, 710, 40. Yang G1, Crawford RC, Wang JH.(2004)Proliferation and collagen production of human patellar tendon fibroblasts in response to cyclic uniaxial stretching in serum-free conditions. J Biomech(10):1543-50. 41. Molloy TJ1, Kemp MW, Wang Y, Murrell GA.(2006)Microarray analysis of the tendinopathic rat supraspinatus tendon: glutamate signaling and its potential role in tendon degeneration.J Appl Physiol(6):1702-9. 42. Perry SM1, McIlhenny SE, Hoffman MC, Soslowsky LJ.(2005 )Inflammatory and angiogenic mRNA levels are altered in a supraspinatus tendon overuse animal model.J Shoulder Elbow Surg.14(1 Suppl S):79S-83S. 43. Glazebrook MA1, Wright JR Jr, Langman M, Stanish WD, Lee JM.(2008)Histological analysis of achilles tendons in an overuse rat model.J Orthop Res.(6):840-6. 44. Stone D1, Green C, Rao U, Aizawa H, Yamaji T, Niyibizi C, Carlin G, Woo SL.(1999)Cytokine-induced tendinitis: a preliminary study in rabbits.J Orthop Res(2):168-77. 45. Simonin MA1, Gegout-Pottie P, Minn A, Gillet P, Netter P, Terlain B.(2000)Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen.Antimicrob Agents Chemother.(4):867-72. 46. Lui PP1, Chan LS, Cheuk YC, Lee YW, Chan KM.(2009)Expression of bone morphogenetic protein-2 in the chondrogenic and ossifying sites of calcific tendinopathy and traumatic tendon injury rat models.J Orthop Surg Res. ;4:27. 47. PK Levangie and CC Noorkin. (2001). Joint structure and function: a comprehension analysis 3rd, F A Davis Co. 48. Chang CH, Liu HC, Lin CC, Chou CH, Lin FH, “Gelatin-chondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering,” Biomaterials, vol. 24, no. 26, 2003, pp. 4853-4858. 49.Wei-Chih Hung, Injectable Hyaluronic Acid / Poly-L-lysine Hydrogel as Cell Carrier for Articular Cartilage Tissue Engineering, master, National Taipei University of Technology, Taipei, 2011. 50. Levangie CC, “Joint structure and function : a comprehensive analysis 3rd ed,” F. A. Davis Company, 2001, pp. 49-83. 51. Laurent, T, “The Biology of Hyaluronan – Introduction,” Ciba Foundation Symposia, vol. 143, 1989, pp. 1-5. 52. Homandberg GA, Hui F, Wen C, Kuettner KE, Williams JM, “Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro,” Osteoarthritis Cartilage, vol. 5, no. 5, 1997, pp. 309-319. 53. Johnna S Temenoffa, Antonios G Mikos, “Review: tissue engineering for regeneration of articular cartilage,” Biomaterials, vol. 21, no. 5, 2000, pp. 431-440. 54. Vercruysse KP, Prestwich GD, “Hyaluronate derivatives in drug delivery,” Crit Rev Ther Drug Carrier Syst, vol. 15, no. 5, 1998, pp. 513-55. 55. Balazs EA, Denlinger JL, “Clinical uses of hyaluronan,” Ciba Foundation Symposium, vol. 143, 1989, pp. 265-275. 56. Carole E. Schante, Guy Zubera, Corinne Herlinb, Thierry F. Vandamme, “Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications,” Carbohydrate Polymers, vol. 85, no. 3, 2011, pp. 469-489. 57. Bulpitt P, Aeschlimann D, “New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels,” J Biomed Mater Res, vol. 47, no. 2, 1999, pp. 152-169. 58. Bigi A, Cojazzi G, Panzavolta S, Roveri N, Rubini K. A, “Stabilization of gelatin films by crosslinking with genipin,” Biomaterials, vol. 23, no. 24, 2002, pp. 4827-4832. 59. Chang CH, Lin HY, Fang HW, Loo ST, Hung SC, Ho YC, Chen CC, Lin FH, Liu HC, “Chondrogenesis from immortalized human mesenchymal stem cells: comparison between collagen gel and pellet culture methods,” Artificial Organs, vol. 32, no. 7, 2008, pp. 561-566. 60. Sung HW, Huang DM, Chang WH, Huang RN, Hsu JC, “Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: In vitro study,” J Biomed Mater Res, vol. 15, no. 4, 1999, pp. 520-530. 61.S.B. Lee(2003). Bio-artificial skin composed of gelatin and (1-3),(1-6)-beta-glucan.,Biomaterial,p.2503-2511 62.Weijia Zhang, Dong Soon Choi.(2013).Studying Cancer Stem Cell Dynamics on PDMS Surfaces for Microfluidics Device Design.Sci Rep.3: 2332. 63. Weiqiang Chen,a Raymond H. W. Lam.(2011).Photolithographic surface micromachining of polydimethylsiloxane (PDMS).Lab Chip. 12(2): 391–395. 64.Nicolas Bosq , Nathanaël Guigo , Jacques Persello.(2014).Melt and glass crystallization of PDMS and PDMS silica nanocomposites.Phys. Chem. Chem. Phys.16, 7830-7840. 65.U S Schwarz, N Q Balaban, D Riveline, A Bershadsky.(2001).Calculation of forces at focal adhesions from elastic substrate data: the effect of localized force and the need for regularization. Biophys J.83(3): 1380–1394. 66. John L. Tan, Joe Tien,Dana M. Pirone.(2003).Cells lying on a bed of microneedles: An approach to isolate mechanical force.Proc Natl Acad Sci U S A.18; 100(4): 1484–1489. 67. B. Gyarmati1(2015) A colourimetric method for the determination of the degree of chemical cross-linking in aspartic acid-based polymer gel. seXPRESS Polymer Letters Vol.9, No.2 154–164. 68.Everse J, Kaplan NO.(1973).Lactate dehydrogenases: structure and function.Adv Enzymol Relat Areas Mol Biol.37:61-133. 69.Promega.Cytotoxicity assay protocol,2006. 70. Lei-Miao Yin, Yin Wei, Yu Wang, Yu-Dong Xu.(2012).Long Term and Standard Incubations of WST-1 Reagent Reflect the Same Inhibitory Trend of Cell Viability in Rat Airway Smooth Muscle Cells. Int J Med Sci. 10(1): 68–72. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78073 | - |
dc.description.abstract | 慢性肌腱炎( Tendinosis)為肌腱反覆過度的使用,或者肌腱受傷得不到完整
的康復,使得肌腱產生慢性發炎的現象。造成肌腱炎的常見原因除了同部位肌 腱的過度使用外,外力創傷、骨關節的錯位與脫臼也容易導致肌腱受傷發炎。 當肌腱發炎的時候,患部通常會產生紅腫、疼痛與僵硬的症狀。雖然使用消炎 止痛的藥物可減少患者的痛楚,但由於其機制目前尚不明確,有別於常見之急 性肌腱炎,許多研究希望能夠找出發炎的原因,進而予以適當的治療。 本研究合成氧化透明質酸(Oxidative hyaluronic acid)與己二酸二醯肼(ADH) 交聯水膠作為抗氧化藥物載體控制釋放,並模擬機械應力誘發慢性肌腱炎之概 念,發展單軸循環拉伸應力裝置(cyclic stress device) 對體外培養6 週Sprague- Dawley 大鼠之肌腱細胞反覆施加拉力,誘發肌腱細胞病變建立慢性肌腱炎細胞 模型。建立慢性肌腱炎細胞模型後,利用抗氧化物兒茶素(EGCG)以及吡拉西坦 (Piracetam)做治療研究,氧化透明質酸(Oxidative hyaluronic acid)與己二酸二醯 肼(ADH)交聯水膠結合兒茶素(EGCG) 控制釋放達到治療慢性肌腱炎(Tendinitis) 的目的。本實驗利用氧化開環法合成氧化透明質酸水膠,並利用傅立葉轉換紅 外線光譜儀、能量散射光譜儀與生物相容性測試等來分析材料特性。此外,利 用即時定量聚合酶聯鎖反應分析第一型膠原蛋白、第三型膠原蛋白、骨化及脂 肪化等基因表現。 經實驗結果顯示,氧化玻尿酸(Oxidative hyaluronic acid)與己二酸二醯肼 (ADH)交聯水膠結合兒茶素(EGCG)具有治療慢性肌腱炎(Tendinitis)的效果。 在未來,我們希望將研究成果應用於動物實驗以及人類慢性肌腱炎的治療 之上。 | zh_TW |
dc.description.abstract | Tendinosis is a degeneration of the tendon’s collagen in response to chronic overuse; when overuse is continued without giving the tendon time to heal and rest, such as with repetitive strain injury, tendinosis results. In addition to repetitive strain injury, trauma、out of joint and osteoarthritis can also cause tendinosis. The symptom of tendinosis are pain, swelling, and stiff. Because of its mechanism which is distinct from the common acute tendinitis is not clear. In spite of the use of anti-inflammatory and analgesic drugs can reduce pain for the patient,many researchers hope to identify the causes of inflammation, and then give the appropriate treatment.
In this study, we use a cyclic stress device to applying tension repeatedly to tendon cells of 6-week-old Sprague-Dawley rats to develop a mechanical-induced tendinosis cell model Additionally, we add antioxidant drugs EGCG and piracetam to research their effects. The oxidized hyaluronic acid with aldehyde funtional groups prepared by sodium periodate was crosslinked by adipic acid dihydrazide (ADH) to form hydrogel to be drug carrier for control-release regimen in tendinosis treatment. We use quantitative real time polymerase chain reaction to analyze gene expression type I collagen, type III collagen, ratio of type III collagen and type I collagen, Runx2, Sox9 and PPARr. To investigate the characterization of hyaluronic acid-based hydrogel, the FTIR, EDS, TNBS and biocopatibility test were evaluated. In the future, we hope to apply results of study on animal tendinitis model and treatment of human tendinitis. Additionally, the cyclic stress device that is developed in the study is more widely used in different studies.such as cardiac and muscle related study . | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T14:41:23Z (GMT). No. of bitstreams: 1 ntu-105-R03548041-1.pdf: 2329593 bytes, checksum: 867fa2669871f1e8934a6d33c66e71c1 (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 誌謝 I
摘要 II Abstract III 表目錄 VII 圖目錄 VIII 第一章 緒論 1 1 .1前言 1 1.2肌腱 1 1.2.1阿基里斯腱 3 1.2.2髕骨肌腱 3 1.3肌腱組織之構造 4 1.4 肌腱炎 5 1.5慢性肌腱炎 5 1.5.1阿基里斯腱炎 5 1.5.2髕骨肌腱炎 6 1.5.3肌腱之力學特性 7 1.6目前治療方法 7 1.6.1 休息 7 1.6.2冰敷 7 1.6.3非類固醇抗發炎藥 7 1.6.4體外衝擊波療法 7 1.6.5物理因子儀器治療 7 1.7兒茶素 8 1.8吡拉西坦 9 1.9研究目的 9 第二章 文獻回顧 10 2.1肌腱的細胞與組成 10 2.1.1肌腱細胞 10 2.1.2肌腱幹細胞 10 2.1.3細胞外間質 11 2.2慢性肌腱炎模型 11 2.2.1機械應力誘發模型 11 2.2.2化學刺激誘發模型 12 2.3材料選用 12 2.3.1透明質酸 12 2.3.2 氧化透明質酸 13 2.3.3明膠 15 2.3.4聚二甲基矽氧烷 16 第三章材料與方法 18 3.1 實驗設備與材料 18 3.2實驗藥品 19 3.4氧化玻尿酸製備 20 3.5氧化透明質酸/己二酸二醯肼水膠製備 20 3.6 配置PDMS溶液 20 3.7 材料分析 21 3.7.1傅立葉轉換紅外線光譜儀 21 3.7.2透明質酸氧化程度分析 22 3.7.3能量散射光譜儀 23 3.8生物相容性評估 23 3.8.1 LDH 細胞毒性測試 24 3.8.2 WST-1 細胞活性測試 25 3.9 肌腱細胞培養與分析 27 3.9.1 肌腱細胞分離 27 3.9.2 肌腱細胞表面抗原分析 28 3.9.3 RNA之純化 29 3.9.4 反轉錄聚合反應 30 3.9.5 即時定量聚合酶聯鎖反應 30 第四章 研究結果與討論 32 4.1氧化玻尿酸性質分析 32 4.1.1能量散射光譜儀分析 32 4.1.2透明質酸氧化程度分析 33 4.1.3傅立葉轉換紅外線光譜儀分析 34 4.2 己二酸二醯肼交聯氧化透明質酸水膠特性分析 35 4.3材料生物相容性評估 36 4.3.1 WST-1生物活性測試 36 4.3.2 LDH 細胞毒性測試 37 4.4藥物生物相容性評估 38 4.4.1 WST-1生物活性測試 38 4.4.2 LDH 細胞毒性測試 39 4.5肌腱細胞表面抗原分析 41 4.6基因表現 42 第五章 結論 47 參考文獻 48 | |
dc.language.iso | zh-TW | |
dc.title | 合成透明質酸水膠作為藥物載體控制釋放做慢性肌腱炎治療之研究 | zh_TW |
dc.title | The preparation of hyaluronic acid-based hydrogel for control-release regimen in tendinosis treatment | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 張國基,楊禎明,陳克紹 | |
dc.subject.keyword | 慢性肌腱炎,透明質酸,聚二甲基矽氧烷,阿基里斯腱,髕骨肌腱, | zh_TW |
dc.subject.keyword | Tendinosis,Hyaluronic acid,PDMS,Achilles tendon,Patellar tendon, | en |
dc.relation.page | 55 | |
dc.identifier.doi | 10.6342/NTU201602986 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-08-21 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
顯示於系所單位: | 醫學工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-R03548041-1.pdf 目前未授權公開取用 | 2.27 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。